Your browser doesn't support javascript.
loading
Sodium Caseinate in Combination With Daunorubicin or Cytarabine Improves Survival of Mice With Long-established Leukemia.
Aguiñiga-Sanchez, Itzen; Ledesma-Martínez, Edgar; Lara-Castañeda, Jose Luis; Melendez-Ibarra, Frida; Weiss-Steider, Benny; Soto-Cruz, Isabel; Fajardo-Orduña, Guadalupe; Santiago-Osorio, Edelmiro.
Afiliação
  • Aguiñiga-Sanchez I; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Ledesma-Martínez E; Department of Biomedical Sciences, School of Medicine, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Lara-Castañeda JL; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Melendez-Ibarra F; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Weiss-Steider B; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Soto-Cruz I; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Fajardo-Orduña G; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
  • Santiago-Osorio E; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
Cancer Diagn Progn ; 2(4): 496-502, 2022.
Article em En | MEDLINE | ID: mdl-35813007

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancer Diagn Progn Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancer Diagn Progn Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México